Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 66.7% increase over the number of companies inspected in the previous year, when three companies were inspected through three inspections.
Most of the companies inspected were involved in the Biologics and Food/Cosmetics sectors. The second most common type of company inspected in the time period worked in the Devices sector.
There were four companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
CSL Plasma, Inc. | Biologics | 11/02/2023 | No Action Indicated (NAI) |
DHM & KPJ Investment, Inc. | Food/Cosmetics | 02/03/2023 | Voluntary Action Indicated (VAI) |
Embraer Aircraft Maintenance Services | Food/Cosmetics | 01/26/2023 | No Action Indicated (NAI) |
Smisson-Cartledge Biomedical, LLC | Devices | 09/15/2023 | No Action Indicated (NAI) |
Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent | Biologics | 12/14/2023 | No Action Indicated (NAI) |